EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark PRÉNUMBRA was filed as Word mark on 02/27/2020 at the European Union Intellectual Property Office.
It was registered as a trademark on 06/27/2020.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018202301 |
| Application date | February 27, 2020 |
| Publication date | March 20, 2020 |
| Entry date | June 27, 2020 |
| Expiration date | February 27, 2030 |
Trademark owner
Devonshire House 60 Goswell Road
EC1M 7AD London
GB
EC1M 7AD London
GB
Trademark representatives
Steinsdorfstraße 14
80538 München
DE
goods and services
5
Pharmaceuticals; pharmaceutical drugs; pharmaceutical preparations; pharmaceuticals used for cerebrovascular accidents (strokes); cardiovascular preparations; cardiovascular pharmaceuticals; cardiovascular pharmaceutical preparations; cardiovascular agents for medical purposes; cardiovascular drugs used in treating shocks; cardiovascular drugs used in myocardial infarctions; cardiovascular drugs used in treating arrhythmias; cardiovascular drugs used in angina pectoris; pharmaceutical preparations for the treatment of cardiovascular disease; cardiovascular drugs used in treating congestive heart failure (CHF); pharmaceutical preparations, preferably based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; sun tanning preparations for pharmaceutical purposes, preferably based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical preparations for skin care; pharmaceutical preparations for treating skin disorders; dermatological preparations; dermatological pharmaceutical substances; dermatological pharmaceutical products; medicinal creams for the protection of the skin; skin care creams for medical use; skin care preparations for medical use; medicated skin creams and lotions; medicated creams for application after exposure to the sun; pharmaceutical skin lotions; preparations for cleansing the skin for medical use; chemical and biological preparations, substances, reagents and compounds for the delivery and storage of pharmaceuticals which are preferably based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; afamelanotide aqueous and gel formulations
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| October 7, 2024 | Change Representative, Published | ||
| January 12, 2023 | Change Representative, Published |
ID: 11018202301